Renalytix AI (GB:RENX) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Renalytix AI has announced the issuance of new shares to repay $1.06 million of its convertible bond principal, reducing the remaining debt to $11.66 million. The company will release over 11 million new ordinary shares and expects these to be admitted to trading on the AIM market by July 17, 2024. Following the admission, Renalytix AI’s total issued share capital will equate to 165,925,513 ordinary shares with corresponding voting rights.
For further insights into GB:RENX stock, check out TipRanks’ Stock Analysis page.